Recent Tech Transfer Deals (07/2010)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

JuneAsuragen Inc. (diagnostics and pharmaceutical services) has licensed non-exclusive rights to Johns Hopkins University's BRAF V600E mutation sequence for use in molecular diagnostics for cancer.

BRAF mutation has been used as a genetic marker for various cancer types. JHU has found that detection of the...

More from Archive

More from Scrip